Cargando…
Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience
There is insufficient evidence on SARS-CoV-2 induced neurological effects. Studies on CNS involvement during COVID-19 in children are limited. This study aims to identify and manage the neurological signs and symptoms in COVID-19-infected pediatric patients during follow up and plan future follow-up...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351517/ https://www.ncbi.nlm.nih.gov/pubmed/35945769 http://dx.doi.org/10.1097/MD.0000000000029920 |
_version_ | 1784762460002058240 |
---|---|
author | Sener Okur, Dicle |
author_facet | Sener Okur, Dicle |
author_sort | Sener Okur, Dicle |
collection | PubMed |
description | There is insufficient evidence on SARS-CoV-2 induced neurological effects. Studies on CNS involvement during COVID-19 in children are limited. This study aims to identify and manage the neurological signs and symptoms in COVID-19-infected pediatric patients during follow up and plan future follow-ups. Children diagnosed COVID-19 and hospitalized in the pediatric pandemic services, between March 18, 2020, and June 18, 2021, were included in the study. Children with underlying neurological disease were excluded from the study. Patient data retrieved from hospital files and medical records. Children divided into 2 groups, 1 and 2, based on the presence or absence of neurological findings. A total of 243 children received follow-ups in the pandemic wards, 35 (14.4%) of these patients had neurological findings. Major neurological manifestations were headache (n:17, 7%), seizure (n:4, 1.6%), and anosmia/hyposmia (n:17, 7%). The number of boys (n:13, 37.1%) was smaller than the number of girls (n:22, 62.9%) in Group 1. Group 1 showed higher blood leukocyte, lymphocyte, thrombocyte, AST, LDH, d-dimer values. Anosmia/hyposmia occurred more often in girls, anosmia and headache occurred more often over 9 years of age. Pulmonary and hematologic involvement was more common in children with anosmia and headache. Our study is one of the few studies on neurological involvement in COVID-19 in children. To the best of our knowledge, there is limited data on these subjects in the literature. |
format | Online Article Text |
id | pubmed-9351517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-93515172022-08-05 Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience Sener Okur, Dicle Medicine (Baltimore) Research Article There is insufficient evidence on SARS-CoV-2 induced neurological effects. Studies on CNS involvement during COVID-19 in children are limited. This study aims to identify and manage the neurological signs and symptoms in COVID-19-infected pediatric patients during follow up and plan future follow-ups. Children diagnosed COVID-19 and hospitalized in the pediatric pandemic services, between March 18, 2020, and June 18, 2021, were included in the study. Children with underlying neurological disease were excluded from the study. Patient data retrieved from hospital files and medical records. Children divided into 2 groups, 1 and 2, based on the presence or absence of neurological findings. A total of 243 children received follow-ups in the pandemic wards, 35 (14.4%) of these patients had neurological findings. Major neurological manifestations were headache (n:17, 7%), seizure (n:4, 1.6%), and anosmia/hyposmia (n:17, 7%). The number of boys (n:13, 37.1%) was smaller than the number of girls (n:22, 62.9%) in Group 1. Group 1 showed higher blood leukocyte, lymphocyte, thrombocyte, AST, LDH, d-dimer values. Anosmia/hyposmia occurred more often in girls, anosmia and headache occurred more often over 9 years of age. Pulmonary and hematologic involvement was more common in children with anosmia and headache. Our study is one of the few studies on neurological involvement in COVID-19 in children. To the best of our knowledge, there is limited data on these subjects in the literature. Lippincott Williams & Wilkins 2022-08-05 /pmc/articles/PMC9351517/ /pubmed/35945769 http://dx.doi.org/10.1097/MD.0000000000029920 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | Research Article Sener Okur, Dicle Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience |
title | Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience |
title_full | Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience |
title_fullStr | Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience |
title_full_unstemmed | Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience |
title_short | Neurological symptoms and signs associated with COVID-19 in pediatric patients: a single-center experience |
title_sort | neurological symptoms and signs associated with covid-19 in pediatric patients: a single-center experience |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351517/ https://www.ncbi.nlm.nih.gov/pubmed/35945769 http://dx.doi.org/10.1097/MD.0000000000029920 |
work_keys_str_mv | AT senerokurdicle neurologicalsymptomsandsignsassociatedwithcovid19inpediatricpatientsasinglecenterexperience |